The overall aim of this Project 1 is to accelerate the development of recombinant paramyosin as a vaccine against schistosomiasisjaponica. Schistosomiasis, caused by three principle species of dioecious trematodes (flatworms), currently infects over 250 million individuals, results in 1.53 million DALYs lost per annum, and contributes to poor health and economic stagnation in endemic areas. Although schistosomiasis is effectively treated with Praziquantel (PZQ), rapid reinfection with rebound morbidity precludes effective control based on chemotherapy alone and justifies current efforts to develop vaccines for these parasites. We will evaluate the efficacy and safety of paramyosin (rSj97), the target of protective Th2 and IgE responses in our human studies, in vaccine trials in water buffalo- a major bovine reservoir of schistosomiasis. We will explore a range of vaccine adjuvants in field- based challenge experiments in water buffalos. We will conclude with a large scale, community based vaccine trial in buffalo designed to test the hypothesis that effective vaccination of water buffalo will reduce the transmission of schistosomiasis japonica to humans. The outcome of these studies will be an optimized, adjuvanted, paramyosin-based vaccine for bovine schistosomiasisjaponica with preclinical data on safety and efficacy in a large animal model.

Public Health Relevance

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-AWA-M)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Research Institute for Tropical Medicine
Muntinlupa City
Zip Code
Botelho, Monica C; Alves, Helena; Richter, Joachim (2017) Halting Schistosoma haematobium - associated bladder cancer. Int J Cancer Manag 10:
Botelho, M C; Alves, H; Richter, J (2017) Estrogen catechols detection as biomarkers in schistosomiasis induced cancer and infertility. Lett Drug Des Discov 14:135-138
Jiz, Mario A; Wu, Haiwei; Olveda, Remigio et al. (2015) Development of Paramyosin as a Vaccine Candidate for Schistosomiasis. Front Immunol 6:347
Olveda, David U; Olveda, Remigio M; Lam, Alfred K et al. (2014) Utility of Diagnostic Imaging in the Diagnosis and Management of Schistosomiasis. Clin Microbiol 3:
Inobaya, Marianette T; Olveda, Remigio M; Chau, Thao Np et al. (2014) Prevention and control of schistosomiasis: a current perspective. Res Rep Trop Med 2014:65-75
Olveda, David U; Li, Yuesheng; Olveda, Remigio M et al. (2013) Bilharzia: Pathology, Diagnosis, Management and Control. Trop Med Surg 1:
Ross, Allen G P; Olveda, Remigio M; Acosta, Luz et al. (2013) Road to the elimination of schistosomiasis from Asia: the journey is far from over. Microbes Infect 15:858-65